Status:
COMPLETED
Registry of Sustained Immunity to COVID-19 Among ESKD Patients
Lead Sponsor:
Davita Clinical Research
Conditions:
SARS-CoV-2 Infection
Anti-SARS-CoV-2 Infection
Eligibility:
All Genders
18-80 years
Brief Summary
This is a multi-center, prospective registry study of subjects undergoing hemodialysis for treatment of end-stage renal disease in a DaVita center. The objective of this study is to understand whethe...
Detailed Description
This is a multi-center, prospective registry study of subjects undergoing hemodialysis for treatment of end-stage renal disease in a DaVita center. The objective of this study is to understand whethe...
Eligibility Criteria
Inclusion
- Between ≥18 and 80 years of age, inclusive.
- Ability to provide informed consent.
- Currently receiving hemodialysis treatment for end-stage kidney disease at a DaVita dialysis center.
Exclusion
- \-
Key Trial Info
Start Date :
July 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 12 2021
Estimated Enrollment :
2315 Patients enrolled
Trial Details
Trial ID
NCT04495764
Start Date
July 20 2020
End Date
February 12 2021
Last Update
May 27 2021
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
DCR Victorville
Victorville, California, United States, 92394
2
DCR Connecticut
Bridgeport, Connecticut, United States, 06606
3
DCR Twin Cities
Minneapolis, Minnesota, United States, 55404
4
DCR Las Vegas
Las Vegas, Nevada, United States, 89128